Podcasts about biosensors

Episode Title: Sleep, Stress, and Exercise for Mental Health with Cognitive Neuroscientist, Justin Verlinden Description: In this episode of the Elevate Yourself podcast, Rob is joined by cognitive neuroscientist, Justin Verlinden, to explore the intersection of sleep, stress, and exercise on mental health. Justin provides valuable insights into how exercise-induced stress impacts the body and how sleep plays a crucial role in helping our bodies recover and recalibrate. Since Justin's last appearance on the show, he's been busy uncovering new findings in his field, and he's excited to share what he's learned. He dives into the science of exercise's effects on stress and how sleep can help us process and recover from it. He also touches on an important question: Does the timing of exercise impact sleep quality, and how does core temperature come into play? As we wrap up the episode, Justin answers rapid-fire questions, giving us a personal peek into his daily routines, insights, and how his thinking has evolved since his last visit. Justin's Bio: Justin Verlinden is a Cognitive Neuroscience PhD Candidate co-mentored by Dr. Lauren Whitehurst and Dr. Jessica Weafer (formerly at University of Kentucky, presently at Ohio State University). Whose research to-date has been centered on the following topics: Sleep as a treatment target for at-risk drinking Sex differences in the relationship between sleep and alcohol use Next-day consequences of drinking on cognition With the help of his mentors and collaborators, he has received training in and utilized a variety of research modalities and skills throughout his career, including: Intravenous alcohol administration Alcohol skin biosensors Polysomnography Actigraphy At-home diaries R programming Feel free to reach out to him via email (justinverlinden@uky.edu) or on IG (@_veezy13) if you would like to learn more about him or his work. He's always happy to nerd out over science :) Selected Publications: Verlinden, J.J., Moloney, M.E., Vsevolozhskaya, O.A., Whitehurst, L.N. and Weafer, J., 2025. Indirect effects of perceived stress and depression on the relationship between insomnia symptoms and hazardous drinking. Alcohol 123: 1-9. https://doi.org/10.1016/j.alcohol.2025.01.001 Verlinden, J.J., Moloney, M.E., Vsevolozhskaya, O.A., Ritterband, L.M., Winkle, F., and Weafer, J. 2023. Effect of a digital cognitive behavioral therapy for insomnia on sleep and alcohol consumption in heavy drinkers: A randomized pilot study. Alcohol Clinical and Experimental Research 47(12):2354-2365. https://doi.org/10.1111/acer.15209 Verlinden, J.J., Moloney, M.E., Whitehurst, L.N., and Weafer, J. 2022. Sex differences in the association between poor sleep quality and alcohol-related problems among heavy drinkers with insomnia. Frontiers in Behavioral Neuroscience 16:875168. https://doi.org/10.3389/fnbeh.2022.875168 Fadel, L.C., Patel, I.V., Romero, J., Tan, I., Kesler, S.R., Rao, V., Subasinghe, S.A., Ray, R.S., Yustein, J.T., Allen, M.J., Gibson, B.W., Verlinden, J.J., Fayn, S., Ruggiero, N., Ortiz, C., Hipskind, E., Feng, A., Iheanacho, C., Wang, A., and Pautler, R.G. 2022. A mouse holder for awake functional imaging in unanesthetized mice: Applications in 31P spectroscopy, manganese-enhanced magnetic resonance imaging studies, and resting-state functional magnetic resonance imaging. Biosensors 12(8): 616. https://doi.org/10.3390/bios12080616 The Elevate Yourself Podcast is brought to you in partnership with Athletic Brewing. Use code ELEVATE30 for 30% OFF your first online order at checkout!

As 2024 comes to a close, join EMJ Editor, Evgenia Koutsouki as she counts down the standout moments from the past year in the final instalment of our Highlights series. This special episode revisits the top six podcasts from 2024, showcasing the groundbreaking ideas, innovations, and expert insights that shaped the healthcare landscape. From exploring the genetic mysteries of parasitic infections to pioneering biosensors for gut health, this festive wrap-up celebrates a year of exceptional conversations and transformative research.   Timestamps:     (00:00)-Introduction   (00:56)-Intersection between parasitology and genetics   (05:55)-Learning from individuals with low cholesterol   (09:56)-Continuous glucose monitoring and insulin pumps   (13:43)-Brain-gut behavioural therapy   (18:47)-Biosensors to treat gut inflammatory disorders   (21:59)-Microbiome monitoring  (25:50)-Wrap up    Featured Episodes:  The Fate of the Cell  Innovations in Vascular Medicine: From Bench to Bedside  A Personalised Approach to Diabetes  Gut Instincts: Bridging Psychology and Gastroenterology  Agar Art and Biosensor Breakthroughs  Microbe Monitoring: New Frontiers in Pathogen Surveillance 

References Nature Methods 2019. volume 16, pages 815–829. Chem Biol Drug Des. 2018 Dec 19;93(6):1251–1264 Biosensors & bioelectronics 2024. Vol 249. 18 January. Crosby, Kantner and Still. 1969. "Wooden Ships". Jefferson Airplane https://youtu.be/ROBaoiJK0wc?si=O1ClTiWkEMFpAEGg Telemann, GF. :"Wassermusik" Ouverture in C major TWV 55:C3 https://youtu.be/ki1asCYcH08?si=p0xnxchR8v5XuYk8 --- Support this podcast: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/support

ST's newest biosensor. The ST1VAFE3BX combines and synchronizes biopotential inputs with an ST accelerometer and a machine learning core, thus opening the way for the next generation of healthcare wearables needing to rein in their energy consumption.

Tian discusses protein function and structure, and the historic city in China where she was born.

Tian discusses protein function and structure, and the historic city in China where she was born.

          Jonathan and Maria Eugenia Inda, Pew Postdoctoral Fellow at MIT Synthetic Biology Center in Cambridge, Massachusetts, discuss the latest developments in microbiome research and their potential applications in personalised health, as well as the fascinating world of agar art. Timestamps:  (00:00)-Introduction (02:57)-Agar art (06:03)-Art influencing the scientific mind (07:40)-Intestinal biosensors  (12:30)-Implications for healthcare professionals (19:35)-Next steps for this technology (23:25)-Synthetic biology (26:23)-The importance of developing communication skills (30:45)-Maria's three wishes for healthcare

Great time in the studio with the Biosensors and Biochips course! The students in the Biochips and Biosensors class of the Department of Biomedical Engineering present their ideas how to solve medical problems using biotechnology and microelectronics. In a Shark Tank like program, their elevator pitches are evaluated by a panel of referees Thank you referees Dr. Oren Zarchin and Dr. Galit Katarivas Levy for your great inputs and feedback! Hosted by: Prof. Hadar Ben Yoav. Recorded and edited by: Dr. Buzi Raviv

This podcast is about big ideas on how technology is making life better for people with vision loss. This episode is about how biosensor technology is revolutionizing the field of diagnostic and preventive medicine. Biosensors can take many forms — wearable, implantable, and even ingestible. And they can serve many different functions as well, most notably when it comes to detecting the various pressure levels in our bodies. This episode features interviews with several luminaries working with biosensors. One of them is Doug Adams, a revolutionary entrepreneur who became inspired to create a biosensor that can assist in the treatment of glaucoma patients, initially focusing on a sensor for intraocular pressure. More recently, Doug founded a company called QURA, whose current efforts are focused on a biosensor that detects blood pressure. To elaborate on QURA's initiatives, this episode also includes insights from its Chief Business Officer, David Hendren. He and Dr. Cal discuss the current state of biosensor technology, the benefits of implantable biosensors, and how they work. Finally, this episode includes a conversation with Max Ostermeier, co-founder and General Manager of Implandata Ophthalmic Products. Max was previously interviewed by Dr. Cal for the episode “Innovations in Intraocular Pressure and Closed Loop Drug Delivery Systems.” This time, Max joins Dr. Cal to discuss the possibilities of biosensor technology and his company's Eyemate system — which includes biosensor technology for glaucoma patients. All three guests also offer their thoughts on the future of biosensors and their endless possibilities. While it may seem like science fiction, it truly is science reality!   The Big Takeaways What Biosensors Do: Currently, biosensors primarily sense the various pressures in the human body. QURA's current sensor detects blood pressure and assists with hypertension. Meanwhile, Implandata's Eyemate technology serves glaucoma patients by gathering data on intraocular pressure. The Rapid Shrinking of Biosensors: When Doug Adams first started working on biosensors, the model he saw was the size of a microwave. Now, it's shrunk to the size of a grain of rice! By making biosensors smaller, they are easier to implant and place in different spots within the body. And by doing so, they can gather more and more data. The Benefits of AI: One drawback of gathering so much data is that it can sometimes be hard to analyze it. However, improvements in AI technology are making it easier to sort through all that data, giving doctors and patients valuable information for medical diagnostics and treatments. The Future of Biosensors: As implantable biosensors become smaller and more sophisticated, all our guests see them becoming a crucial part of healthcare. In addition to gathering data on all sorts of functions within the body, biosensors could provide therapies and treatments with minimal human intervention.   Tweetables: So, we are measuring the absolute pressure inside the eye with this kind of technology. It originates from the automotive industry. Tire pressure sensors, where you also have to measure the pressure inside the tire. And so basically we took set technology and advanced it and made it so small that you can also implant this kind of sensor in an eye. — Max Ostermeier, co-founder and General Manager of Implandata Ophthalmic Products So I had a physical a month ago, and along with the physical, they draw blood, and they send that blood off to a lab. I have a feeling in the next decade, that goes away. Why do you have to send a vial of blood to the lab? Because if I had a sensor, not even in an artery, but on top of an artery, I could do a complete analysis of everything in that blood that you're doing from the lab. — Doug Adams, entrepreneur and founder of QURA The important thing is that you are automatically getting data to the care group that is taking care of these patients, where they are able to see what's happening. They're able to see not just a snapshot once in a while, as you'd have from an external pressure cuff, but [get] continuous data longitudinally. — David Hendren, Chief Business Officer of QURA   Contact Us: Contact us at podcasts@lighthouseguild.org with your innovative new technology ideas for people with vision loss.   Pertinent Links Lighthouse Guild QURA Implandata Ophthalmic Products

Meridith Cass - the Founder-CEO of Nix BioSensors - joins the show to talk about the self-health movement, the latest technology behind hydration intelligence, and the prospect of completely automating your hydration strategy and execution at an ultra-trail race like the Western States 100. One thing to note before we get started - Singletrack has no financial partnership with Nix, but if you're interested in trying out their products after listening to this episode feel free to use the code Singletrack15 for 15% off your order on their website.Timestamps:2:10 The Importance of Self-Health and Personalized Health Management5:15 Accuracy and Meaningful Metrics in Biosensing8:34 Personalized Feedback and Dynamic Recommendations10:05 The Limitations of Intuition in Hydration Management12:26 The Impact of Dehydration on Performance14:17 How the Nix Patch Works and Measures Sweat15:06 Refining Hydration Plans with Patch Data17:30 The Nix Index and Environmental Conditions21:05 The Value of Wearing the Patch Before and After Workouts23:42 Triangulating Data with Other Sensors25:04 Accuracy of Recommendations and Tolerable Error Rate27:24 The Role of the Patch in Changing Consumer Purchasing and Brand Marketing29:30 Granularity of Electrolyte Profile Data31:06 The Future of Hydration and the Role of the Nix Patch37:09 The Impact of Nix on Personalized Purchasing Decisions39:39 The Need for Lab-Based Sweat Tests and the Role of the Nix Patch41:00 Exciting Research in Sweat Science and Partnerships with Researchers42:27 Automating Hydration Strategies with the Nix PatchSponsors:Naak - use code SINGLETRACK15 at checkout on their website (https://www.naak.com/) to get 15% off your purchase.Rabbit - use code Singletrack20 at checkout on their website (https://www.runinrabbit.com/) to get 20% off your next order.Brooks Running - check out their High Point clothing collection and new and improved Cascadia 17 shoe at this link (https://www.brooksrunning.com/singletrack).deltaG Ketones - use code Singletrack20 at checkout on their website (https://www.deltagketones.com/SINGLETRACK20) to get 20% off your next order.Links:Connect with Meridith on LinkedIn, WebsiteFollow Singletrack on Instagram, Strava, YoutubeSupport the show

In today's episode, we dive into the world of eye tracking technology and how it's transforming the landscape of human factors research setups. We covered why eye tracking is more applicable than ever, hosting three expert speakers from the University of North Dakota. Furthermore, iMotions spoke on the multi-modal approach for enhanced insights. Listen in to learn moreLinks of interest: [Watch] Expanding Human Insights: Combining Eye Tracking with Biosensors to Assist University Research Labs: https://smarteye.se/webinars/expanding-human-insights-combining-eye-tracking-with-biosensors-to-assist-university-research-labs/[Read] UND puts Humvee through its paces, assisted by minivan mom: Me - https://blogs.und.edu/und-today/2023/10/und-puts-humvee-through-its-paces-assisted-by-minivan-mom-me/[Read] Unleashing the Power of Smart Eye: Transforming Research Capabilities at UND / RIAS - https://smarteye.se/blog/unleashing-the-power-of-smart-eye-eye-tracking-transforms-research-capabilities-at-und-rias/

References J Biol Chem 2017 292: 20481. Nature Cell Biology 2019. volume 21, pages 338–347 Rossini.G. 1829. William Tell Overture. https://youtu.be/z7Tj2SzToHI?si=QUXkj3NzqF17Zq60 Vivaldi, A. 1712. Concerto in D Major. RV 212. https://youtu.be/l21_9KKy1Pg?si=9HSMxRj7huJF1B8j --- Send in a voice message: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/message Support this podcast: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/support

In today's episode, we dive into a recent collaborative event Smart Eye attended at the University of North Dakota (or UND) and the Research Institute for Autonomous Systems (RIAS). With a comprehensive setup featuring multiple cameras, EEG data collection modules, and emotion sensing capabilities, the UND RIAS team is poised to unlock the true potential of eye tracking technology combined with other biosensors. Speaking with Smart Eye, UND Professor and project sponsor Philip Brandt and the students involved in this week-long tech event, we got a comprehensive look into their project, which includes equipping a HUMVEE with advanced Smart Eye Pro eye tracking systems and iMotions analysis software. This state-of-the-art arrangement provides a powerful platform for capturing and analyzing data related to driver and passenger behavior, setting the stage for groundbreaking research. Listen to learn more!Links of interest: [Watch] Expanding Human Insights: Combining Eye Tracking with Biosensors to Assist University Research Labs - https://smarteye.se/webinars/expanding-human-insights-combining-eye-tracking-with-biosensors-to-assist-university-research-labs/[Read] UND puts Humvee through its paces, assisted by minivan mom: Me - https://blogs.und.edu/und-today/2023/10/und-puts-humvee-through-its-paces-assisted-by-minivan-mom-me/[Read] Unleashing the Power of Smart Eye: Transforming Research Capabilities at UND / RIAS - https://smarteye.se/blog/unleashing-the-power-of-smart-eye-eye-tracking-transforms-research-capabilities-at-und-rias/

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPK865. CME/MOC/AAPA credit will be available until December 12, 2024.Addressing Unmet Needs in Anticoagulation for Thrombosis: Next-Generation Strategies for Improving Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from the Bristol Myers Squibb and Janssen Alliance.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerRoxana Mehran, MD, has a financial interest/relationship or affiliation in the form of:Grant/Research Support from Abbott; ABIOMED; Affluent Medical; Alleviant Medical; Amgen Inc.; AM-Pharma B.V.; Arena Pharmaceuticals, Inc.; AstraZeneca; AtriCure Inc.; Biosensors; BIOTRONIK SE & Co KG; Boston Scientific Corporation; Bristol Myers Squibb; CardiaWave; Celonova Biosciences Inc.; Chiesi USA, Inc.; Concept Medical; Cytosorbents Europe GmbH; Daiichi Sankyo Inc.; Duke; Element Science, Inc.; Faraday Pharmaceuticals; Humacyte, Inc.; Idorsia Pharmaceuticals Ltd; Janssen Pharmaceuticals, Inc.; Koninklijke Philips N.V.; Magenta Therapeutics; M.A. Med Alliance SA; MediaSphere Medical LLC; Medtelligence; Medtronic; MJH Life Sciences; Novartis Pharmaceuticals Corporation; OrbusNeich Medical Company Group Holdings Limited; Penumbra, Inc.; PhaseBio Pharmaceuticals, Inc.; Pi-Cardia; PLx Pharma Inc.; Protembis GmbH; RenalPro; RM Global Partners; Shockwave Medical Inc.; Vivasure Medical Limited; and ZOLL Medical Corporation.Honoraria from ACC (BOT Member, SC Member CTR Program) and JAMA Cardiology (Associate Editor).Stock Shareholder in Applied Therapeutics and Elixir Therapeutics, LLC.Other Financial or Material Support in the form of personal fees from Affluent Medical; Cardiovascular Research Foundation; Daiichi Sankyo Brasil; ER Squibb & Sons LLC; Esperion Therapeutics, Inc.; Europa Group/Boston Scientific Corporation; Gaffney Events Educational Trust; Ionis Pharmaceuticals; IQVIA Inc; J-CalC; McVeigh Global Meetings and Events; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Oversome; Primer Healthcare of New Jersey; Radcliffe Institute for Advanced Study; SL Solutions LLC; TARSUS Cardiology; Vectura Group Ltd; and Vox Media, LLC.Co-Chair/PlannerJeffrey Weitz, MD, FRCPC, FRSC, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Alnylam Pharmaceuticals, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo Co., Ltd.; Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Honoraria from Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPK865. CME/MOC/AAPA credit will be available until December 12, 2024.Addressing Unmet Needs in Anticoagulation for Thrombosis: Next-Generation Strategies for Improving Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from the Bristol Myers Squibb and Janssen Alliance.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerRoxana Mehran, MD, has a financial interest/relationship or affiliation in the form of:Grant/Research Support from Abbott; ABIOMED; Affluent Medical; Alleviant Medical; Amgen Inc.; AM-Pharma B.V.; Arena Pharmaceuticals, Inc.; AstraZeneca; AtriCure Inc.; Biosensors; BIOTRONIK SE & Co KG; Boston Scientific Corporation; Bristol Myers Squibb; CardiaWave; Celonova Biosciences Inc.; Chiesi USA, Inc.; Concept Medical; Cytosorbents Europe GmbH; Daiichi Sankyo Inc.; Duke; Element Science, Inc.; Faraday Pharmaceuticals; Humacyte, Inc.; Idorsia Pharmaceuticals Ltd; Janssen Pharmaceuticals, Inc.; Koninklijke Philips N.V.; Magenta Therapeutics; M.A. Med Alliance SA; MediaSphere Medical LLC; Medtelligence; Medtronic; MJH Life Sciences; Novartis Pharmaceuticals Corporation; OrbusNeich Medical Company Group Holdings Limited; Penumbra, Inc.; PhaseBio Pharmaceuticals, Inc.; Pi-Cardia; PLx Pharma Inc.; Protembis GmbH; RenalPro; RM Global Partners; Shockwave Medical Inc.; Vivasure Medical Limited; and ZOLL Medical Corporation.Honoraria from ACC (BOT Member, SC Member CTR Program) and JAMA Cardiology (Associate Editor).Stock Shareholder in Applied Therapeutics and Elixir Therapeutics, LLC.Other Financial or Material Support in the form of personal fees from Affluent Medical; Cardiovascular Research Foundation; Daiichi Sankyo Brasil; ER Squibb & Sons LLC; Esperion Therapeutics, Inc.; Europa Group/Boston Scientific Corporation; Gaffney Events Educational Trust; Ionis Pharmaceuticals; IQVIA Inc; J-CalC; McVeigh Global Meetings and Events; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Oversome; Primer Healthcare of New Jersey; Radcliffe Institute for Advanced Study; SL Solutions LLC; TARSUS Cardiology; Vectura Group Ltd; and Vox Media, LLC.Co-Chair/PlannerJeffrey Weitz, MD, FRCPC, FRSC, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Alnylam Pharmaceuticals, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo Co., Ltd.; Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Honoraria from Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPK865. CME/MOC/AAPA credit will be available until December 12, 2024.Addressing Unmet Needs in Anticoagulation for Thrombosis: Next-Generation Strategies for Improving Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from the Bristol Myers Squibb and Janssen Alliance.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerRoxana Mehran, MD, has a financial interest/relationship or affiliation in the form of:Grant/Research Support from Abbott; ABIOMED; Affluent Medical; Alleviant Medical; Amgen Inc.; AM-Pharma B.V.; Arena Pharmaceuticals, Inc.; AstraZeneca; AtriCure Inc.; Biosensors; BIOTRONIK SE & Co KG; Boston Scientific Corporation; Bristol Myers Squibb; CardiaWave; Celonova Biosciences Inc.; Chiesi USA, Inc.; Concept Medical; Cytosorbents Europe GmbH; Daiichi Sankyo Inc.; Duke; Element Science, Inc.; Faraday Pharmaceuticals; Humacyte, Inc.; Idorsia Pharmaceuticals Ltd; Janssen Pharmaceuticals, Inc.; Koninklijke Philips N.V.; Magenta Therapeutics; M.A. Med Alliance SA; MediaSphere Medical LLC; Medtelligence; Medtronic; MJH Life Sciences; Novartis Pharmaceuticals Corporation; OrbusNeich Medical Company Group Holdings Limited; Penumbra, Inc.; PhaseBio Pharmaceuticals, Inc.; Pi-Cardia; PLx Pharma Inc.; Protembis GmbH; RenalPro; RM Global Partners; Shockwave Medical Inc.; Vivasure Medical Limited; and ZOLL Medical Corporation.Honoraria from ACC (BOT Member, SC Member CTR Program) and JAMA Cardiology (Associate Editor).Stock Shareholder in Applied Therapeutics and Elixir Therapeutics, LLC.Other Financial or Material Support in the form of personal fees from Affluent Medical; Cardiovascular Research Foundation; Daiichi Sankyo Brasil; ER Squibb & Sons LLC; Esperion Therapeutics, Inc.; Europa Group/Boston Scientific Corporation; Gaffney Events Educational Trust; Ionis Pharmaceuticals; IQVIA Inc; J-CalC; McVeigh Global Meetings and Events; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Oversome; Primer Healthcare of New Jersey; Radcliffe Institute for Advanced Study; SL Solutions LLC; TARSUS Cardiology; Vectura Group Ltd; and Vox Media, LLC.Co-Chair/PlannerJeffrey Weitz, MD, FRCPC, FRSC, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Alnylam Pharmaceuticals, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo Co., Ltd.; Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Honoraria from Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPK865. CME/MOC/AAPA credit will be available until December 12, 2024.Addressing Unmet Needs in Anticoagulation for Thrombosis: Next-Generation Strategies for Improving Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from the Bristol Myers Squibb and Janssen Alliance.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerRoxana Mehran, MD, has a financial interest/relationship or affiliation in the form of:Grant/Research Support from Abbott; ABIOMED; Affluent Medical; Alleviant Medical; Amgen Inc.; AM-Pharma B.V.; Arena Pharmaceuticals, Inc.; AstraZeneca; AtriCure Inc.; Biosensors; BIOTRONIK SE & Co KG; Boston Scientific Corporation; Bristol Myers Squibb; CardiaWave; Celonova Biosciences Inc.; Chiesi USA, Inc.; Concept Medical; Cytosorbents Europe GmbH; Daiichi Sankyo Inc.; Duke; Element Science, Inc.; Faraday Pharmaceuticals; Humacyte, Inc.; Idorsia Pharmaceuticals Ltd; Janssen Pharmaceuticals, Inc.; Koninklijke Philips N.V.; Magenta Therapeutics; M.A. Med Alliance SA; MediaSphere Medical LLC; Medtelligence; Medtronic; MJH Life Sciences; Novartis Pharmaceuticals Corporation; OrbusNeich Medical Company Group Holdings Limited; Penumbra, Inc.; PhaseBio Pharmaceuticals, Inc.; Pi-Cardia; PLx Pharma Inc.; Protembis GmbH; RenalPro; RM Global Partners; Shockwave Medical Inc.; Vivasure Medical Limited; and ZOLL Medical Corporation.Honoraria from ACC (BOT Member, SC Member CTR Program) and JAMA Cardiology (Associate Editor).Stock Shareholder in Applied Therapeutics and Elixir Therapeutics, LLC.Other Financial or Material Support in the form of personal fees from Affluent Medical; Cardiovascular Research Foundation; Daiichi Sankyo Brasil; ER Squibb & Sons LLC; Esperion Therapeutics, Inc.; Europa Group/Boston Scientific Corporation; Gaffney Events Educational Trust; Ionis Pharmaceuticals; IQVIA Inc; J-CalC; McVeigh Global Meetings and Events; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Oversome; Primer Healthcare of New Jersey; Radcliffe Institute for Advanced Study; SL Solutions LLC; TARSUS Cardiology; Vectura Group Ltd; and Vox Media, LLC.Co-Chair/PlannerJeffrey Weitz, MD, FRCPC, FRSC, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Alnylam Pharmaceuticals, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo Co., Ltd.; Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Honoraria from Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPK865. CME/MOC/AAPA credit will be available until December 12, 2024.Addressing Unmet Needs in Anticoagulation for Thrombosis: Next-Generation Strategies for Improving Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from the Bristol Myers Squibb and Janssen Alliance.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerRoxana Mehran, MD, has a financial interest/relationship or affiliation in the form of:Grant/Research Support from Abbott; ABIOMED; Affluent Medical; Alleviant Medical; Amgen Inc.; AM-Pharma B.V.; Arena Pharmaceuticals, Inc.; AstraZeneca; AtriCure Inc.; Biosensors; BIOTRONIK SE & Co KG; Boston Scientific Corporation; Bristol Myers Squibb; CardiaWave; Celonova Biosciences Inc.; Chiesi USA, Inc.; Concept Medical; Cytosorbents Europe GmbH; Daiichi Sankyo Inc.; Duke; Element Science, Inc.; Faraday Pharmaceuticals; Humacyte, Inc.; Idorsia Pharmaceuticals Ltd; Janssen Pharmaceuticals, Inc.; Koninklijke Philips N.V.; Magenta Therapeutics; M.A. Med Alliance SA; MediaSphere Medical LLC; Medtelligence; Medtronic; MJH Life Sciences; Novartis Pharmaceuticals Corporation; OrbusNeich Medical Company Group Holdings Limited; Penumbra, Inc.; PhaseBio Pharmaceuticals, Inc.; Pi-Cardia; PLx Pharma Inc.; Protembis GmbH; RenalPro; RM Global Partners; Shockwave Medical Inc.; Vivasure Medical Limited; and ZOLL Medical Corporation.Honoraria from ACC (BOT Member, SC Member CTR Program) and JAMA Cardiology (Associate Editor).Stock Shareholder in Applied Therapeutics and Elixir Therapeutics, LLC.Other Financial or Material Support in the form of personal fees from Affluent Medical; Cardiovascular Research Foundation; Daiichi Sankyo Brasil; ER Squibb & Sons LLC; Esperion Therapeutics, Inc.; Europa Group/Boston Scientific Corporation; Gaffney Events Educational Trust; Ionis Pharmaceuticals; IQVIA Inc; J-CalC; McVeigh Global Meetings and Events; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Oversome; Primer Healthcare of New Jersey; Radcliffe Institute for Advanced Study; SL Solutions LLC; TARSUS Cardiology; Vectura Group Ltd; and Vox Media, LLC.Co-Chair/PlannerJeffrey Weitz, MD, FRCPC, FRSC, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Alnylam Pharmaceuticals, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo Co., Ltd.; Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Honoraria from Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPK865. CME/MOC/AAPA credit will be available until December 12, 2024.Addressing Unmet Needs in Anticoagulation for Thrombosis: Next-Generation Strategies for Improving Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from the Bristol Myers Squibb and Janssen Alliance.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerRoxana Mehran, MD, has a financial interest/relationship or affiliation in the form of:Grant/Research Support from Abbott; ABIOMED; Affluent Medical; Alleviant Medical; Amgen Inc.; AM-Pharma B.V.; Arena Pharmaceuticals, Inc.; AstraZeneca; AtriCure Inc.; Biosensors; BIOTRONIK SE & Co KG; Boston Scientific Corporation; Bristol Myers Squibb; CardiaWave; Celonova Biosciences Inc.; Chiesi USA, Inc.; Concept Medical; Cytosorbents Europe GmbH; Daiichi Sankyo Inc.; Duke; Element Science, Inc.; Faraday Pharmaceuticals; Humacyte, Inc.; Idorsia Pharmaceuticals Ltd; Janssen Pharmaceuticals, Inc.; Koninklijke Philips N.V.; Magenta Therapeutics; M.A. Med Alliance SA; MediaSphere Medical LLC; Medtelligence; Medtronic; MJH Life Sciences; Novartis Pharmaceuticals Corporation; OrbusNeich Medical Company Group Holdings Limited; Penumbra, Inc.; PhaseBio Pharmaceuticals, Inc.; Pi-Cardia; PLx Pharma Inc.; Protembis GmbH; RenalPro; RM Global Partners; Shockwave Medical Inc.; Vivasure Medical Limited; and ZOLL Medical Corporation.Honoraria from ACC (BOT Member, SC Member CTR Program) and JAMA Cardiology (Associate Editor).Stock Shareholder in Applied Therapeutics and Elixir Therapeutics, LLC.Other Financial or Material Support in the form of personal fees from Affluent Medical; Cardiovascular Research Foundation; Daiichi Sankyo Brasil; ER Squibb & Sons LLC; Esperion Therapeutics, Inc.; Europa Group/Boston Scientific Corporation; Gaffney Events Educational Trust; Ionis Pharmaceuticals; IQVIA Inc; J-CalC; McVeigh Global Meetings and Events; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Oversome; Primer Healthcare of New Jersey; Radcliffe Institute for Advanced Study; SL Solutions LLC; TARSUS Cardiology; Vectura Group Ltd; and Vox Media, LLC.Co-Chair/PlannerJeffrey Weitz, MD, FRCPC, FRSC, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Alnylam Pharmaceuticals, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo Co., Ltd.; Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Honoraria from Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPK865. CME/MOC/AAPA credit will be available until December 12, 2024.Addressing Unmet Needs in Anticoagulation for Thrombosis: Next-Generation Strategies for Improving Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from the Bristol Myers Squibb and Janssen Alliance.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerRoxana Mehran, MD, has a financial interest/relationship or affiliation in the form of:Grant/Research Support from Abbott; ABIOMED; Affluent Medical; Alleviant Medical; Amgen Inc.; AM-Pharma B.V.; Arena Pharmaceuticals, Inc.; AstraZeneca; AtriCure Inc.; Biosensors; BIOTRONIK SE & Co KG; Boston Scientific Corporation; Bristol Myers Squibb; CardiaWave; Celonova Biosciences Inc.; Chiesi USA, Inc.; Concept Medical; Cytosorbents Europe GmbH; Daiichi Sankyo Inc.; Duke; Element Science, Inc.; Faraday Pharmaceuticals; Humacyte, Inc.; Idorsia Pharmaceuticals Ltd; Janssen Pharmaceuticals, Inc.; Koninklijke Philips N.V.; Magenta Therapeutics; M.A. Med Alliance SA; MediaSphere Medical LLC; Medtelligence; Medtronic; MJH Life Sciences; Novartis Pharmaceuticals Corporation; OrbusNeich Medical Company Group Holdings Limited; Penumbra, Inc.; PhaseBio Pharmaceuticals, Inc.; Pi-Cardia; PLx Pharma Inc.; Protembis GmbH; RenalPro; RM Global Partners; Shockwave Medical Inc.; Vivasure Medical Limited; and ZOLL Medical Corporation.Honoraria from ACC (BOT Member, SC Member CTR Program) and JAMA Cardiology (Associate Editor).Stock Shareholder in Applied Therapeutics and Elixir Therapeutics, LLC.Other Financial or Material Support in the form of personal fees from Affluent Medical; Cardiovascular Research Foundation; Daiichi Sankyo Brasil; ER Squibb & Sons LLC; Esperion Therapeutics, Inc.; Europa Group/Boston Scientific Corporation; Gaffney Events Educational Trust; Ionis Pharmaceuticals; IQVIA Inc; J-CalC; McVeigh Global Meetings and Events; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Oversome; Primer Healthcare of New Jersey; Radcliffe Institute for Advanced Study; SL Solutions LLC; TARSUS Cardiology; Vectura Group Ltd; and Vox Media, LLC.Co-Chair/PlannerJeffrey Weitz, MD, FRCPC, FRSC, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Alnylam Pharmaceuticals, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo Co., Ltd.; Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Honoraria from Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPK865. CME/MOC/AAPA credit will be available until December 12, 2024.Addressing Unmet Needs in Anticoagulation for Thrombosis: Next-Generation Strategies for Improving Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from the Bristol Myers Squibb and Janssen Alliance.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerRoxana Mehran, MD, has a financial interest/relationship or affiliation in the form of:Grant/Research Support from Abbott; ABIOMED; Affluent Medical; Alleviant Medical; Amgen Inc.; AM-Pharma B.V.; Arena Pharmaceuticals, Inc.; AstraZeneca; AtriCure Inc.; Biosensors; BIOTRONIK SE & Co KG; Boston Scientific Corporation; Bristol Myers Squibb; CardiaWave; Celonova Biosciences Inc.; Chiesi USA, Inc.; Concept Medical; Cytosorbents Europe GmbH; Daiichi Sankyo Inc.; Duke; Element Science, Inc.; Faraday Pharmaceuticals; Humacyte, Inc.; Idorsia Pharmaceuticals Ltd; Janssen Pharmaceuticals, Inc.; Koninklijke Philips N.V.; Magenta Therapeutics; M.A. Med Alliance SA; MediaSphere Medical LLC; Medtelligence; Medtronic; MJH Life Sciences; Novartis Pharmaceuticals Corporation; OrbusNeich Medical Company Group Holdings Limited; Penumbra, Inc.; PhaseBio Pharmaceuticals, Inc.; Pi-Cardia; PLx Pharma Inc.; Protembis GmbH; RenalPro; RM Global Partners; Shockwave Medical Inc.; Vivasure Medical Limited; and ZOLL Medical Corporation.Honoraria from ACC (BOT Member, SC Member CTR Program) and JAMA Cardiology (Associate Editor).Stock Shareholder in Applied Therapeutics and Elixir Therapeutics, LLC.Other Financial or Material Support in the form of personal fees from Affluent Medical; Cardiovascular Research Foundation; Daiichi Sankyo Brasil; ER Squibb & Sons LLC; Esperion Therapeutics, Inc.; Europa Group/Boston Scientific Corporation; Gaffney Events Educational Trust; Ionis Pharmaceuticals; IQVIA Inc; J-CalC; McVeigh Global Meetings and Events; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Oversome; Primer Healthcare of New Jersey; Radcliffe Institute for Advanced Study; SL Solutions LLC; TARSUS Cardiology; Vectura Group Ltd; and Vox Media, LLC.Co-Chair/PlannerJeffrey Weitz, MD, FRCPC, FRSC, FACP, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Alnylam Pharmaceuticals, Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Daiichi Sankyo Co., Ltd.; Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Honoraria from Ionis Pharmaceuticals; Janssen Inc.; Merck & Co., Inc.; Pfizer; and Servier Canada.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

In this podcast episode, MRS Bulletin's Sophia Chen interviews Surabhi Madhvapathy of Northwestern University about an implantable bioelectronics system that can perform early detection of kidney transplant rejection in rats. Madhvapathy and her colleagues have developed a wireless sensor that attaches to the kidney itself. The biosensor measures the organ's temperature and its thermal conductivity. These can point toward inflammation in the kidney, which can be a sign of organ rejection. This work was published in a recent issue of Science.

Tech companies are in vogue as they continue to change the world, but an ASX-listed company is looking to transform the electrochemical testing space.See omnystudio.com/listener for privacy information.

Wastewater, the world's dirty (not so little) secret, consumes nearly 3 percent of the global electricity demand. It's a staggering statistic, and yet much of what actually happens with wastewater remains a mystery. Treatment plants typically purify water by infusing it with oxygen, creating an environment where bacteria can break down waste. But without proper sensors or data, the method is incredibly energy-intensive. Plus with an influx of unregulated chemicals, our waste streams are becoming more toxic and harder to clean. In this episode of Solve for X, environmental microbiologist Patrick Kiely shares his unusual solution that harnesses the power of bacteria to help solve our wastewater problem. Unpleasant yet fascinating, Kiely's work offers a glimpse into what it takes to clean our water and why treating wastewater is the next big climate problem. Featured in this episode:Patrick Kiely is the CEO and founder of SENTRY, a real-time monitoring biosensor system for wastewater treatment. With extensive training in environmental microbiology, his unique knowledge of bacterial growth across diverse environments forms the basis for advanced decision-making in water and wastewater technologies.Further Reading:How tackling wastewater can help corporations achieve climate goalsPhosphorus saved our way of life — and now threatens to end it“Water scarcity on a scale that we haven't seen before” is comingThe energy sector should care about wastewaterGovernment of Canada backs innovative company pioneering new wastewater treatment technology MaRS helps entrepreneurs looking to scale solutions in climate tech, health and software. We offer targeted support through our Capital and Growth Acceleration programs. To learn more visit us at marsdd.com

Today on AtoZrunning: We wrap up our Biosensor series by examining with Meridith Cass one of the most important aspects for runners: hydration In running news, NCAA cross country conference action was crazy, including some upsets, some predictable outcomes, and more! Big Dog's backyard ultra saw the world's best meet, and they did not disappoint How fast can 11 year olds run a 5k? Crazy fast! For resources and details, visit https://atozrunning.com/episode213  For training, coaching, and other services, visit https://atozrunning.com/coaching

This week on AtoZrunning: What's going on in the biosensor industry? We kick off a multi-week series to address the technology and what it does and can do for runners. Is it a good thing for the sport? We'll find out. In running news, Boston marathon champ Des Linden is getting a new heart. What's that all about? Also, according to Runner's World, breathing matters, but we're probably doing it wrong, apparently And it's about time to discuss cross country as we begin to enter championship season All this and more coming up on AtoZrunning! For resources and details, visit https://atozrunning.com/episode211  For training, coaching, and other services, visit https://atozrunning.com/coaching

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Key messages of the new ESC Guidelines on the Management of Acute Coronary Syndromes "Long COVID" and the heart Mythbusters: Is it true that “Weekend Warriors” experience no health benefits? Host: Susanna Price Guests: Carlos Aguiar, Robert Byrne and Eric Topol. Want to watch that episode? Go to: https://esc365.escardio.org/event/1136   Disclaimer This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.   Declarations of interests Stephan Achenbach, Nicolle Kraenkel, Susanna Price and Eric Topol have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Robert Byrne has declared to have potential conflicts of interest to report: research funding from healthcare industry under your direct/personal responsibility (to department or institution) for Biosensors (clinical trial activity, principal investigator), Boston Scientific (research/educational grant to institution of employment to support fellowship programme, clinical director), Abbott Vascular (research/educational grant to institution of employment to support fellowship programme, clinical director), Translumina :(research/educational grant to institution of employment to support research nurse for patient outcomes, clinical director). Membership or affiliation in political or advocacy groups working in the field of cardiology: ESC representative at Biomedical Alliance Member of Irish Heart Attack Audit Governance Committee Member Health Products, Regulatory Authority (HPRA; Irish Competent Authority) Advisory Committee on Medical Devices, Deputy Editor at EuroIntervention Guest Editor at Circulation. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

Most rare diseases are incurable. Biosensors are a technology that, driven by continuous advances in artificial intelligence, can help disease detection, lower the cost of novel therapies, replace placebo groups in clinical trials and foster patient-centred, personalised (e)-medicine. - Original publication on the EP Think Tank website - Subscription to our RSS feed in case your have your own RSS reader - Podcast available on Deezer, iTunes, TuneIn, Stitcher, YouTube Source: © European Union - EP

Scientists are measuring the activity of neurotransmitters to create a chemical map of the brain.

(0:42) - A Spy In The Belly--As always, you can find these and other interesting & impactful engineering articles on Wevolver.com.To learn more about this show, please visit our shows page. By following the page, you will get automatic updates by email when a new show is published. Be sure to give us a follow and review on Apple podcasts, Spotify, and most of your favorite podcast platforms!

Today, I'm joined by Meridith Cass, founder & CEO of Nix Biosensors, creators of a biometric patch that extracts real-time hydration data from human sweat. Through a reusable wearable device, Nix gives individuals the access and tools to understand their health in terms of sweat rate, electrolyte loss rate, and sweat composition. Its flagship product helps endurance athletes track, analyze, and strategize hydration, optimizing performance with a recommended combination of fluids and fuel. In this episode, Meridith details the technology behind the company's sweat-tracking patch and why Nix is focused on endurance athletes before expanding into new markets. In this episode, you'll learn: • How Meridith's background in VC is guiding her development of Nix • How the Nix Hydration Biosensor captures electrochemical biomarkers • Nix's initial GTM strategy and its surprise organic growth across additional markets Nix Biosensor's Website: nixbiosensors.com Subscribe to the podcast → insider.fitt.co/podcast Subscribe to our newsletter → insider.fitt.co/subscribe Follow us on LinkedIn → linkedin.com/company/fittinsider/ - The Fitt Insider podcast is brought to you by Jack Taylor, our exclusive PR partner. More than just PR, they're creative storytellers and brand builders who actually understand the health and wellness industry. Learn more and get in touch at JackTaylorPR.com/Fitt Chapters: (00:00) Introduction (01:41) Meridith's background (03:23) Launching Nix Biosensors  (05:28) The product and platform (06:24) Nix's value proposition (07:51) Hydration management (11:41) Real time hydration notifications and suggestions  (14:42) Customer use cases (18:15) Recommendations based on personalized data (21:03) The Nix team and current state of the business (24:28) Hydration tracking: From athletes to general consumers  (27:17) Focusing on endurance athletes first (30:58) Potential opportunities and markets (33:31) Future roadmap and upcoming product updates  (35:28) Improving the product through feedback (37:42) Conclusion

References The Journal of Biological Chemistry 2007.282,11356-11364. BMC Biology 2011. 9:85 Cancer Res . 2011 Jan 15;71(2):293-7. J BiolChem. 2023 Mar; 299(3): 103019. --- Send in a voice message: https://podcasters.spotify.com/pod/show/dr-daniel-j-guerra/message

This week we discuss some recent articles and research, followed by a chat with CEO of Nix Biosensors, Meridith Cass. We cover: ✔ If body shape and size affects performance in the heat  ✔ If wearing calf sleeves prevents GI issues in the marathon  ✔ A deep dive into Nix Biosensors  ✔ The importance of sweat rate and composition  ✔ A whole lot  more!  Want to be featured on the show? Email us at fuelforthesolepodcast@gmail.com to be featured.  This episode is fueled by ASICS! Head over to ASICS.com and sign up for a OneASICS account. It's completely free and when you sign up you will receive 10% off your first purchase. You also gain access to exclusive colorways on ASICS.com, free standard shipping, special birthday month discounts and more. --- Send in a voice message: https://podcasters.spotify.com/pod/show/fuelforthesole/message

Today's episode features Smart Eye Deputy CEO Dr. Rana El Kaliouby (formerly Co-Founder and CEO of Affectiva) moderating a discussion with Pernille Bülow, PhD, founder and CEO of the nonprofit Mind Blossom, and Loren Larsen of Videra Health. On this last day of Mental Health Awareness month, these three came together to put a spotlight on this issue, and delve into the role technologies like Emotion AI can play in mental health. The panelists also discussed the ethical concerns surrounding the use of technology in mental health and how they can be addressed. Additionally, they examine the potential impact of this tech on mental health research and how it can be used to identify new treatments and therapies. The discussion highlights the potential of recent technology advancements to revolutionize the way we approach mental health and underscores the importance of responsible and ethical use of this technology. Listen in to learn more. Links of interest: [Watch Now] Biosensors in mental health research:  https://attendee.gotowebinar.com/register/7812277932273402896?source=podcast[Blog] iMotions: Bringing Mental Health to the Forefront https://imotions.com/blog/learning/product-news/bringing-mental-health-to-the-forefront/[Podcast Episode] iMotions: Emotion AI & Biosensors in Mental Health Research:  https://podcasts.apple.com/us/podcast/imotions-emotion-ai-biosensors-in-mental-health-research/id1458361251?i=1000585494254[Blog] How eye trackers can help us understand mental health issues around performance anxiety: https://smarteye.se/blog/how-eye-trackers-can-help-us-understand-mental-health-issues-in-performance-anxiety/

Meridith Cass is CEO and Founder of Nix Biosensors, the game changing consumer hydration biosensor company responsible for pioneering a revolutionary biosensor and app that measures hydration levels in real-time from sweat amount to electrolyte loss. This innovation is sweeping the sports and endurance sports landscape as well as helping soldiers and laborers monitor their hydration needs and avoid the negative effects of dehydration. Meridith was just included on Inc.'s 2023 Female Founder 200 List, a group of leaders whose innovations and leadership are creating positive change in the world.  Meridith founded Nix with the mission to change the way we practice healthcare by providing new tools to help consumers access, understand, and act on their personal biology outside traditional settings of healthcare. We talk about Nix Biosensors, where the idea for the company and hydration biosensor began, the connection between sweat and electrolyte loss to athletic performance and how this varies for everyone, the many benefits and biometrics the Nix Hydration Biosenor has to offer and how the company is growing.  We talk about the exercise and wellness that fuel Meridith for success, what she is reading and watching in her spare time! Cass is a graduate of Bryn Mawr College, where she received the Anna Pell Wheeler Prize in Mathematics, a Harvard Business School graduate, a Kauffman Fellow, and a Harvard Business School Blavatnik Fellow. Prior to starting Nix, Cass worked with several Boston and New York based venture capital firms in the creation of seven life science and consumer portfolio companies, leveraging a venture creation model. She is a former collegiate basketball player-turned-runner and has run nine marathons including all of the World Majors. Cass is a staunch believer that truly disruptive innovation in healthcare will be driven by highly personalized data in the hands of the consumer, and that this model has the power to transform today's sick-care system into a practice of proactive health care. CONNECT Nix Biosesnsors on Instagram Marni On The Move Instagram, Facebook, TikTok, LinkedIn, or YouTube Marni Salup on Instagram and Spotify SUBSCRIBE TO OUR NEWSLETTER Sign up for our weekly newsletter, The Download, for Marni on the Move updates, exclusive offers, invites to events, and exciting news! SUPPORT THE PODCAST Leave us a review on Apple. It's easy, scroll through the episode list on your podcast app, click on five stars, click on leave a review, and share what you love about the conversations you're listening to. Tell your friends to what you love on social. Screenshot or share directly from our stories the episode you're listening to, tag us and the guests, and use our new Marni on the Move Giphy!

Commentary by Dr. Candice Silversides and Dr. Animesh Tandon

On Rensselaer Polytechnic Institute Week: Shayla Sawyer, professor of electrical, computer, and systems engineering, explores a metal-breathing bacterium dramatically improves biosensors for aquatic ecosystems Shayla Sawyer is a professor in the Electrical, Computer, and Systems Engineering Department at Rensselaer Polytechnic Institute. Her Nano-Bio Optoelectronics research program expands the fundamental understanding, engineering processes, and potential applications […]

TO WATCH ALL FLYOVER CONTENT: theflyoverapp.comWATCH FULL SHOW: https://rumble.com/v2bitxc-clay-clark-live-interview-from-a-to-z-everything-you-need-to-know-about-the.html Clay ClarkWEBSITE: www.timetofreeamerica.comPODCAST: www.thrivetimeshow.comFOR ALL INFORMATION FROM CLAY:► Text CLAY to 40509(Message and data rates may apply. Terms/privacy: 40509-info.com)For Tickets to a ReAwaken America Event - text the word FLYOVER to 918-851-0102SPONSORS FOR TODAY'S VIDEO► ReAwaken America- text the word EVENTS to 40509(Message and data rates may apply. Terms/privacy: 40509-info.com)► Kirk Elliott PHD - http://FlyoverGold.com ► My Pillow - https://MyPillow.com/Flyover► Z-Stack - https://flyoverhealth.com ► Dr. Jason Dean (BraveTV) - https://parakiller.com Want to help spread the Wake Up • Speak Up • Show Up -https://shop.flyoverconservatives.com/-------------------------------------------Follow our Social Media so we can be best friends

TO WATCH ALL FLYOVER CONTENT: theflyoverapp.comWATCH FULL SHOW: https://rumble.com/v2bitxc-clay-clark-live-interview-from-a-to-z-everything-you-need-to-know-about-the.html Clay ClarkWEBSITE: www.timetofreeamerica.comPODCAST: www.thrivetimeshow.comFOR ALL INFORMATION FROM CLAY:► Text CLAY to 40509(Message and data rates may apply. Terms/privacy: 40509-info.com)For Tickets to a ReAwaken America Event - text the word FLYOVER to 918-851-0102SPONSORS FOR TODAY'S VIDEO► ReAwaken America- text the word EVENTS to 40509(Message and data rates may apply. Terms/privacy: 40509-info.com)► Kirk Elliott PHD - http://FlyoverGold.com ► My Pillow - https://MyPillow.com/Flyover► Z-Stack - https://flyoverhealth.com ► Dr. Jason Dean (BraveTV) - https://parakiller.com Want to help spread the Wake Up • Speak Up • Show Up -https://shop.flyoverconservatives.com/-------------------------------------------Follow our Social Media so we can be best friends

Today's episode features prior guest Dr. Pernille Bülow, Product Specialist at iMotions where she consults and trains researchers on multimodal biometric data collection and study design. Penny speaks with Dr. Ryan Jane Jacoby, who is a licensed clinical psychologist at the Center for OCD and Related Disorders at Massachusetts General Hospital and an Assistant Professor of Psychology (Psychiatry) at Harvard Medical School. Her clinical & research interests focus on the behavioral/psychophysiological measurement of transdiagnostic psychological processes using multi-method approaches.From investigations into clinical mental illness regarding bipolar disorder, depression and PTSD, to general health monitoring, education, and performance, multimodal biosensor studies have seen blossoming interest. These two experts covered how combining facial expression analysis, heart rate, eye tracking, skin conductance or other multi-sensor behavioral research techniques can have immediate implications on the clinical, diagnostic or intervention aspects of mental health research.Listen to learn more. [Webinar] see the reference slides in the full recording:  iMotions client webinar: Biosensors in mental health research -  https://register.gotowebinar.com/register/7812277932273402896?source=podcast[Blog] Eye Tracking & Biosensors in Mental Health Research: https://smarteye.se/blog/eye-tracking-biosensors-in-mental-health-research/[Blog] How eye trackers can help us understand mental health issues around performance anxiety: https://smarteye.se/blog/how-eye-trackers-can-help-us-understand-mental-health-issues-in-performance-anxiety/[Podcast] Driving the Future of Neurological Development Research: Thriving with Eye Tracking and Biosensors: https://smarteye.se/podcasts/driving-the-future-of-neurological-development-research-thriving-with-eye-tracking-and-biosensors/[Podcast] An Emotion AI Chat on Biosensors in Mental Health Research: https://smarteye.se/podcasts/an-emotion-ai-chat-on-biosensors-in-mental-health-research/[Podcast] What Biosensors Reveal in Test Anxiety Research: an iMotions Customer Chat: https://smarteye.se/podcasts/what-biosensors-reveal-in-test-anxiety-research-an-imotions-customer-chat/[Podcast] iMotions: Emotion AI & Biosensors in Mental Health Research: https://smarteye.se/podcasts/imotions-emotion-ai-biosensors-in-mental-health-research/

Today we meet up again with James Wilkes, founder, and Max Rünzel, CEO, of Hive Tracks. The people at HiveTracks have raised the bar when it come to gathering data about your bees, your bee yards, the environment in which they live. The data also provides a look at what role climate change may or may not play in how well they are doing now and in the future. The data entered by beekeepers using the HiveTracks app, is analyzed and reported back to the beekeeper helping him or her make knowledge-based decisions that help them throughout the season. Listen today as James and Max talk about the new directions they are taking HiveTracks to further the use of bees as biosensors – first data collectors of the environments they visit on their journeys. This is fascinating and exciting journey you will definitely want to learn about. We hope you enjoy the episode. Leave comments and questions in the Comments Section of the episode's website. Thank you for listening! Links and websites mentioned in this podcast:  HiveTracks: https://www.hivetracks.com/  HiveTracks WeFund: https://wefunder.com/HiveTracks Beekeeping Today Podcast on YouTube: https://www.youtube.com/@beekeepingtodaypodcast Honey Bee Obscura: https://www.honeybeeobscura.com ______________ This episode is brought to you by Global Patties! Global offers a variety of standard and custom patties. Visit them today at http://globalpatties.com and let them know you appreciate them sponsoring this episode!  We welcome Betterbee as sponsor of today's episode. Betterbee's mission is to support every beekeeper with excellent customer service, continued education and quality equipment. From their colorful and informative catalog to their support of beekeeper educational activities, including this podcast series, Betterbee truly is Beekeepers Serving Beekeepers. See for yourself at www.betterbee.com Thanks to Strong Microbials for their support of Beekeeping Today Podcast. Find out more about heir line of probiotics in our Season 3, Episode 12 episode and from their website: https://www.strongmicrobials.com We welcome HiveAlive back as an episode sponsor. HiveAlive is the #1 liquid feed supplement for honeybees worldwide.  It contains a unique blend of seaweed extracts, thyme and lemongrass proven to increase bee strength, produce more honey, improved bee gut health and improved overwinter survival. Ask about HiveAlive and new HiveAlive Fondant & Pollen Patty at your local beekeeping store or visit the website www.usa.hivealivebees.com for more information. Listeners of the podcast can claim a special discount online using the code "BTP" at the checkout! Thanks for Northern Bee Books for their support. Northern Bee Books is the publisher of bee books available worldwide from their website or from Amazon and bookstores everywhere. They are also the publishers of The Beekeepers Quarterly and Natural Bee Husbandry. _______________ We hope you enjoy this podcast and welcome your questions and comments in the show notes of this episode or: questions@beekeepingtodaypodcast.com Thanks to Bee Culture, the Magazine of American Beekeeping, for their support of The Beekeeping Today Podcast. Available in print and digital at www.beeculture.com Thank you for listening!  Podcast music: Be Strong by Young Presidents; Epilogue by Musicalman; Walking in Paris by Studio Le Bus; A Fresh New Start by Pete Morse; Original guitar background instrumental by Jeff Ott Beekeeping Today Podcast is an audio production of Growing Planet Media, LLC Copyright © 2023 by Growing Planet Media, LLC

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Cardiac involvement in Fabry's Disease Anti-thrombotic therapy post PCI: DAPT in 2023  Mythbusters: Powernap for heart health Host: Rick Grobbee Guests: Perry Elliott, Nicolle Kraenkel, Roxana Mehran and Franz Weidinger Want to watch that episode? Go to: https://esc365.escardio.org/event/896 Disclaimer This programme is intended for health care professionals only and is to be used for educational purposes.  The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.  Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.  Declarations of interests  Stephan Achenbach, Rick Grobbee, Nicolle Kraenkel and Franz Weidinger have declared to have no potential conflicts of interest to report.  Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.  Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.  Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Sanofi. Roxana Mehran has declared to have potential conflicts of interest to report: institutional research payments from Abbott, Abiomed, Alleviant Medical, Amgen, AM-Pharma, Arena, AstraZeneca, Atricure, Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi, Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence, Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll;  personal fees from Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD; Equity

Crystal fact checks a fact checker at DARPA about Profusa biosensors and announces, “New evidence suggests that the truth is a lie.” -CC --- Send in a voice message: https://anchor.fm/more-morgellons/message Support this podcast: https://anchor.fm/more-morgellons/support

Today's episode features a Product Specialist at iMotions, Dr. Pernille Bülow. iMotions is a fully-integrated, hardware-agnostic software platform that allows researchers to use the power of any neuroscience technology, as well as traditional surveys and focus groups, to gain unparalleled insight into what people actual think and feel. Their customers use iMotions for everything from diagnosis of neurological diseases such as Parkinson, Schizophrenia, Autism and Alzheimers to personnel training, UX testing, advertising and military human research. At iMotions, Pernille consults and trains academic and commercial researchers on multimodal biometric data collection and study design. Pernille finished her BS at UC Berkeley and completed her PhD in Neuroscience at Emory University where she studied brain mechanisms associated with the neurodevelopmental disorder Fragile X Syndrome. Pernille is passionate about sharing her knowledge to help others create ground-breaking science.We talked about the use of biosensors in development (particularly in infants), some examples of where tools like eye tracking can be applied in mental health research, and how this technology can help the neurodivergent and neurotypical thrive. Listen in to learn more. Links of interest: Register for the iMotions client webinar: Biosensors in mental health research  - https://attendee.gotowebinar.com/register/7812277932273402896?source=podcastiMotions blog: Bringing Mental Health to the Forefront https://imotions.com/blog/learning/product-news/bringing-mental-health-to-the-forefront/iMotions: Emotion AI & Biosensors in Mental Health Research:  https://podcasts.apple.com/us/podcast/imotions-emotion-ai-biosensors-in-mental-health-research/id1458361251?i=1000585494254How eye trackers can help us understand mental health issues around performance anxiety: https://smarteye.se/blog/how-eye-trackers-can-help-us-understand-mental-health-issues-in-performance-anxiety/

Mental health research takes many forms, but what unites it can be the application of biosensors and psychophysiological methodologies to better understand and ameliorate patient experiences and outcomes.Today's episode features iMotions Product Specialist Dr. Pernille Bülow and Deputy CEO of Smart Eye (formerly Co-Founder and CEO of Affectiva) Dr. Rana el Kaliouby.The two had a great discussion Emotion AI in mental health applications, the role of biosensors like eye tracking in mental health research and where this technology is heading in the future. Links of interest: Register for the iMotions client webinar: Biosensors in mental health research  - https://attendee.gotowebinar.com/register/7812277932273402896?source=podcastiMotions blog: Bringing Mental Health to the Forefront https://imotions.com/blog/learning/product-news/bringing-mental-health-to-the-forefront/iMotions: Emotion AI & Biosensors in Mental Health Research:  https://podcasts.apple.com/us/podcast/imotions-emotion-ai-biosensors-in-mental-health-research/id1458361251?i=1000585494254

Today's episode features iMotions Product Specialist Dr. Pernille Bülow and Dr. Erick Bourassa, an Associate Professor in the Department of Biological Sciences and Physician Assistant Studies at Mississippi College. iMotions is a fully-integrated, hardware-agnostic software platform that allows researchers to use the power of any neuroscience technology, as well as traditional surveys and focus groups, to gain unparalleled insight into what people actual think and feel. At iMotions, Pernille consults and trains academic and commercial researchers on multimodal biometric data collection and study design.We are joined by iMotions customer Dr. Bourassa, who joined MC's faculty in 2014 and currently teaches Vertebrate Histology, Pharmacology, Virology, Cell Physiology, Pharmacology of Infectious Diseases, and Pharmacology & Therapeutics. One area of his research expertise includes alterations of normal attention and memory in patients with anxiety disorders. Currently, his research efforts are focused on identifying the abnormal neural circuitry that induces and maintains anxiety in patients with anxiety disorders.The three talked about mental health in education and performance research, the role of biosensors in mental health research and Dr. Bourassa's work in studying test anxiety in students using biosensors. Listen to learn more. Links of interest: Register for Biosensors in Mental Health Research webinar: https://attendee.gotowebinar.com/register/7812277932273402896?source=podcast Dr. Erick Bourassa Faculty Profile: https://www.mc.edu/faculty/u/EABourassaWatch the Emotion AI in Mental Health Research livestream feat. Dr. Rana el Kaliouby & Dr. Pernille Bulow: https://www.linkedin.com/video/event/urn:li:ugcPost:6998331377548992512/iMotions Blog: Bringing Mental Health to the Forefront content series: https://imotions.com/blog/learning/product-news/bringing-mental-health-to-the-forefront/Emotion AI & Biosensors in Mental Health Research Podcast: https://podcasts.apple.com/us/podcast/imotions-emotion-ai-biosensors-in-mental-health-research/id1458361251?i=1000585494254

Today's episode features a Product Specialist at iMotions, Dr. Pernille Bülow. iMotions is a fully-integrated, hardware-agnostic software platform that allows researchers to use the power of any neuroscience technology, as well as traditional surveys and focus groups, to gain unparalleled insight into what people actual think and feel. Their customers use iMotions for everything from diagnosis of neurological diseases such as Parkinson, Schizophrenia, Autism and Alzheimers to personnel training, UX testing, advertising and military human research. At iMotions, Pernille consults and trains academic and commercial researchers on multimodal biometric data collection and study design. Pernille finished her BS at UC Berkeley and completed her PhD in Neuroscience at Emory University where she studied brain mechanisms associated with the neurodevelopmental disorder Fragile X Syndrome. Pernille is passionate about sharing her knowledge to help others create ground-breaking science.We talked about Emotion AI in mental health applications, the role of biosensors in mental health research and where this technology is heading in the future. Listen in to learn more. Links of interest: Register for webinar: iMotions client webinar: Biosensors in mental health research here  - https://attendee.gotowebinar.com/register/7812277932273402896?source=podcast Smart Eye blog: https://smarteye.se/blog/Follow Rana on LinkedIn to watch the Livestream: https://www.linkedin.com/in/kaliouby/ iMotions: Bringing Mental Health to the Forefront: https://imotions.com/blog/mental-health-focus/v

Meridith Cass is a former collegiate and current endurance athlete with a background in startups in emerging health technology. She is building a company that will advance wearable with real time biometric data. Learn more about your ad choices. Visit megaphone.fm/adchoices

Meridith Cass is a former collegiate and current endurance athlete with a background in startups in emerging health technology. She is building a company that will advance wearable with real time biometric data.

Digital technology has transformed our lives. For people living with multiple sclerosis, electronic health opens a new world. Biosensors in our smartphones and wearable devices can monitor physical activity levels and sleep and may detect MS disease changes faster than that next neurologist appointment. New apps can help people with MS manage and track their disease including gaming to assess cognition. Digital health is becoming an indispensable part of in-office and virtual patient appointments. Privacy concerns with electronic healthcare addressed. Treatment decisions facing both doctors and patients are getting increasingly complex. New artificial intelligence technology may soon help personalize treatment and predict treatment response using a concept of a digital twin. Barry Singer MD, Director of The MS Center for Innovations in Care interviews: Jennifer Graves MD PhD is an Associate Professor at UC San Diego School of Medicine and serves as Director of the UC San Diego Neuroimmunology Research Program. Dr. Graves completed a fellowship in neuro-ophthalmology and residency in neurology at the University of Pennsylvania Perelman School of Medicine. She earned her medical degree and PhD in molecular biophysics from University of Texas Southwestern Medical School. She also holds a master's degree in epidemiology and biostatistics from UC San Francisco. Tjalf Ziemssen MD PhD is founder and director of the MS Center in Dresden, Germany where he did his neurology training. Professor Ziemssen is also Director of the Center of Clinical Neuroscience and the neuroimmunological lab at the Carl Gustav Carus University Hospital in Dresden. He completed his medical training and doctoral thesis at the University of Bochum. He also was a research fellow at the Max Planck Institute of Neurobiology.